Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1Phase 1/2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Breast Neoplasms 10Neoplasms 5Carcinoma, Non-Small-Cell Lung 4Pain, Postoperative 3Neurotoxicity Syndromes 3Melanoma 3Leukemia, Myeloid, Acute 3Brain Neoplasms 3Recurrence 2Ovarian Neoplasms 2Hemorrhage 2Chronic Pain 2Agnosia 2Vulvodynia 1Uterine Cervical Neoplasms 1Stomatitis 1Stomach Neoplasms 1Spinal Cord Neoplasms 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Seizures 1Radiodermatitis 1Radiation Injuries 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Complications 1Peripheral Nervous System Diseases 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Parathyroid Neoplasms 1Papillomavirus Infections 1Pancreatic Neoplasms 1

Interventions

Methotrexate 48Cyclophosphamide 47Vincristine 39Cytarabine 36Dexamethasone 33Mercaptopurine 32pegaspargase 30Doxorubicin 29Daunorubicin 26Etoposide 24Asparaginase 23Prednisone 22Radiotherapy 18Thioguanine 15Leucovorin 14Calcium Dobesilate 14merphos 12Prednisolone 12blinatumomab 11Hydrocortisone 10Whole-Body Irradiation 9dexamethasone acetate 8azathiopurine 8Methylprednisolone 8Ifosfamide 8Filgrastim 8Cyclosporine 8fludarabine 7dexamethasone 21-phosphate 7auricularum 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Sodium Chloride × Clear all
NCT04095858 2023-02-08

CATHY

Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Phase 3 Terminated
11 enrolled 10 charts
LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡